Who
Aaron Berg
President and CEO
Company insider
Files Form 4 as: President and CEO, Amarin Corporation.
In numbers
- Trades disclosed
- 252
- Buys
- 1
- Sells
- 4
- Bought
- $102K
- Sold
- $5.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 May 2019
- Last trade
- 26 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 30 Jun 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —6,250 | filing |
| 26 Jun 2026filed 30 Jun 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $52K3,197 at $16.35 | filing |
| 26 Jun 2026filed 30 Jun 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,250 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,250 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —6,250 | filing |
| 26 Jun 2026filed 30 Jun 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $52K3,197 at $16.35 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,793 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,566 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,793 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,566 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —2,246 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $19K1,235 at $15.42 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —1,933 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,246 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,933 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $16K1,063 at $15.42 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,246 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,933 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —2,246 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $19K1,235 at $15.42 | filing |
News
Voter's Guide: Aaron Berg (Incumbent)hometownsource.com · 8 Oct 2026Amarin (NASDAQ:AMRN) and Merck KGaA (OTCMKTS:MKKGY) Financial ReviewAMRN · themarketsdaily.com · 11 Oct 2026
1 headline in the last 90 days name Aaron Berg; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.